Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 18,36118,380 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Identifying multi-level barriers and facilitators to digital health use in federally qualified health centers
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Colorectal cancer (CRC) is a leading cause of cancer death in the United States. National guidelines recommend that average risk people receive regular CRC...

$502.4K
USD
Completed NON-SBIR/STTR RPGS
Dissecting Single-cell Response or Resistance to Novel Combination Therapy in AML using Mass Cytometry
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2022

PROJECT SUMMARY This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-21-034. Acute myeloid leukemia (AML) is among the dead...

$1.47M
USD
Completed TRAINING, INDIVIDUAL
Contribution of ERa/PR Crosstalk to Endocrine Therapy Resistance in the Context of ERa-Y537S
NATIONAL CANCER INSTITUTE University of Chicago United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT Half of estrogen receptor (ER?)-positive breast cancer patients treated with endocrine therapies manifest intrinsic or acquired therapy resistance. One-thi...

$460.4K
USD
Completed OTHER RESEARCH-RELATED
Regulation and function of exosomal cargo loading in cancer progression
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2023

Regulation and function of exosomal cargo loading in cancer progression Exosomes are 50-150 nm, endosome-derived, extracellular vesicles that are secreted by most cells.The exosome...

$1.78M
USD
Completed OTHER RESEARCH-RELATED
Elucidating the impact of DNA hypomethylation on genome organization and anti-tumor transcriptional programs.
NATIONAL CANCER INSTITUTE Massachusetts General Hospital United States 2021 – 2021

PROJECT SUMMARY This proposed research career development program seeks to investigate the impact of DNA hypomethylation on genome organization and the mechanisms by which it drive...

$870.5K
USD
Completed OTHER RESEARCH-RELATED
Developing novel CAR T cell designs using combinatorial antigen detection
NATIONAL CANCER INSTITUTE University of California, San Francisco United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Candidate: The applicant, Greg Allen, MD/PhD, is a medical oncologist at UCSF with a long-term goal to lead an independent laboratory-based translational r...

$2.87M
USD
Completed NON-SBIR/STTR RPGS
Differential biophysical properties of protein condensates formed by a tumor suppressor contribute to sexual dimorphism in cancer
NATIONAL CANCER INSTITUTE University of Virginia United States 2021 – 2023

PROJECT SUMMARY It remains incompletely understood why men are more likely to get and die from cancer than women.Tumor suppressor genes that escape from X-inactivation substantiall...

$4.15M
USD
Completed NON-SBIR/STTR RPGS
New Hybrid Molecular Modalities Comprised of DNA-Origami and Interfering Peptides as Inhibitors of Protein-Protein Interactions
NATIONAL CANCER INSTITUTE George Mason University United States 2021 – 2024

PROJECT SUMMARY/ABSTRACT: New molecular modalities to target sites of protein-protein interaction with high affinity and specificity are desperately needed in cancer treatment.Bloc...

$1.99M
USD
Completed NON-SBIR/STTR RPGS
Interplay between tumor and microenvironment in bone metastasis
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2021 – 2026

Prostate cancer (CaP) is the most commonly diagnosed cancer and the second leading cause of cancer death in men over the age of fifty. Bone is the primary site of metastasis in pat...

$4.71M
USD
Completed NON-SBIR/STTR RPGS
Addressing Chemoresistance in Pancreatic and Ovarian Cancers: Photodynamic Priming and Repurposing of Tetracyclines using Targeted Photo-Activable Multi-Inhibitor Liposome
NATIONAL CANCER INSTITUTE University of Maryland, College Park United States 2021 – 2026

ABSTRACT The prognosis for patients with advanced stage ovarian or pancreatic cancer has remained dismal for decades.The poor response rates result, in part, from resistance to sal...

$6.73M
USD
Completed NON-SBIR/STTR RPGS
Exploiting Urine Derived DNA for the Assessment of Bladder Cancer using High Accuracy Sequencing
NATIONAL CANCER INSTITUTE University of Washington United States 2021 – 2023

PROJECT SUMMARY Many attempts have been made to develop urine-based biomarkers for bladder cancer surveillance and monitoring. However, the most widely used approach, urine cytolog...

$1.82M
USD
Completed NON-SBIR/STTR RPGS
The Role of Base Excision Repair in Regulating DNA-Mediated Inflammatory Signaling Pathways
NATIONAL CANCER INSTITUTE University of Texas At Austin United States 2021 – 2023

PROJECT SUMMARY Defects in DNA repair underlie a number of human genetic diseases that affect a wide variety of physiological systems and cause adverse phenotypes such as accelerat...

$2.12M
USD
Completed NON-SBIR/STTR RPGS
Breast cancer virotherapy
NATIONAL CANCER INSTITUTE University of Illinois At Chicago United States 2021 – 2023

Breast cancer is the most frequently diagnosed cancer in women worldwide.Despite advances in early detection and treatment, a notable fraction of patients progress to metastatic di...

$1.87M
USD
Completed NON-SBIR/STTR RPGS
TRIM37 is a genetic determinant of racial disparity in metastatic TNBC patients
NATIONAL CANCER INSTITUTE University of Virginia United States 2021 – 2021

African American (AA) women presents with aggressive metastatic subtype of triple negative breast cancer (TNBC) compared to other ethnicities and experience greater mortality rates...

$1.4M
USD
Completed NON-SBIR/STTR RPGS
Chemical manipulation of creatine kinases to treat acute myeloid leukemia
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2023

PROJECT SUMMARY: Over the last decade, essential metabolic dependencies of many cancers have been revealed.These dependencies have highlighted that certain nodes of metabolism are...

$4.51M
USD
Completed NON-SBIR/STTR RPGS
HULLK, a novel lncRNA that functions as a targetable oncogene in PCa
NATIONAL CANCER INSTITUTE University of Virginia United States 2021 – 2024

Abstract There remains a critical need for more effective therapies for prostate cancer and for castration resistant prostate cancer.While localized prostate cancer (PCa) has a fav...

$4.11M
USD
Completed NON-SBIR/STTR RPGS
Faithful mouse modeling of human lung cancer
NATIONAL CANCER INSTITUTE University of Pittsburgh At Pittsburgh United States 2021 – 2021

Abstract Lung cancer is the leading cause of cancer-related deaths in both men and women with a 5-year survival rate of only 19%.Although PD-1 immune checkpoint blockade therapy ma...

$167.7K
USD
Completed NON-SBIR/STTR RPGS
Shifting the immune infiltrates in osteosarcoma lung metastases with locally targeted CSF-1Ris for combination therapies
NATIONAL CANCER INSTITUTE Virginia Commonwealth University United States 2021 – 2023

PROJECT SUMMARY/ABSTRACT Osteosarcoma (OS) is the most common type of primary malignancy of the bone. OS metastasizes primarily to the lungs, with pulmonary disease being the leadi...

$3.99M
USD
Completed NON-SBIR/STTR RPGS
FEN1-Nuclease-Targeted Therapy for Ewing Sarcoma
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2021 – 2026

PROJECT SUMMARY Ewing Sarcoma Family of Tumors (ESFT) are bone and soft tissue cancers that affect children and adolescents.Surgery, radiation and multi-agent chemotherapy have imp...

$5.74M
USD
Completed NON-SBIR/STTR RPGS
Quantitative Analyses of HER2 Upregulation in Luminal Breast Cancer in Response to Neoadjuvant Endocrine Therapy
NATIONAL CANCER INSTITUTE Medical College of Wisconsin United States 2021 – 2023

Project Description Endocrine therapy provides significant improvement in long-term outcomes for patients with estrogen receptor- positive (ER+) breast cancer (BC), also known as l...

$887.8K
USD